Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors

Ähnliche Einträge

• Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer
  von: Guo, Renhua, et al.
  Veröffentlicht: (2011)
• Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
  von: Yu, Helena A., et al.
  Veröffentlicht: (2014)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  von: Westover, D, et al.
  Veröffentlicht: (2018)
• Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
  von: Li, Xin, et al.
  Veröffentlicht: (2018)
• A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition
  von: Zhang, Nana, et al.
  Veröffentlicht: (2017)